UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Huons wins nod for endoscope sterilizer
Huons Medicare, a biotechnology firm, said Tuesday that it has won the regu...
by Shim Hyun-tai
|
2020-06-16 18:06
라인
Sanofi releases hemophilia A treatment
Sanofi Aventis Korea said Tuesday that it was launching a hemophilia A trea...
by Shim Hyun-tai
|
2020-06-16 17:27
라인
Korea moves to speed up Covid-19 vaccines’ entry into clinical trials
The Ministry of Food and Drug Safety (MFDS) issued guidelines on Tuesday to...
by Shim Hyun-tai
|
2020-06-16 16:49
라인
Sillajen CEO steps down
Sillajen CEO Moon Eun-sang has resigned from his post.Moon’s resignation ca...
by Lee Han-soo
|
2020-06-16 16:49
라인
MSD fails to present plausible reasons, grounds for discriminating against branches
Last Thursday, MSD Korea's labor union took issue with the expanded imp...
by Lee Han-soo
|
2020-06-16 16:21
라인
KIST finds method to detect 20 genes simultaneously
Local researchers said they have developed a test method that can simultane...
by Song Soo-youn
|
2020-06-16 16:21
라인
Gemvax & Kael's GV1001 shows efficacy as hepatitis B treatment
Gemvax & Kael said that it has confirmed the efficacy of GV1001 in treating...
by Lee Han-soo
|
2020-06-16 16:18
라인
Despite slight letup in local infections, imported cases rise back
The local spread of Covid-19 slowed down on Monday, which was offset by the...
by Lee Han-soo
|
2020-06-16 14:07
라인
Daily Covid-19 tests surpass earlier testing surge in Daegu
Continued cluster infections of Covid-19 in greater Seoul led the number of...
by Kwak Sung-sun
|
2020-06-16 12:50
라인
‘Celltrion has no reason to save Takeda Korea workers’ jobs’
Takeda Pharmaceutical’s sell-off of part of its business to Celltrion is ex...
by Kim Yun-mi
|
2020-06-16 11:44
라인
SCL transfers diagnostic tech to Indonesia
Seoul Clinical Laboratories (SCL), an organization specializing in diagnost...
by Shim Hyun-tai
|
2020-06-15 17:40
라인
AI developed to pick out adenoma without biopsy
Researchers at Seoul National University Hospital Gangnam Center have devel...
by Lee Han-soo
|
2020-06-15 17:40
라인
New AI model reads MRI image of inner ear disorder
A research team of Samsung Medical Center has developed an artificial intel...
by Shim Hyun-tai
|
2020-06-15 17:40
라인
Jardiance family of diabetes drugs sells ₩10 billion in Q1
The Jardiance family of diabetes drugs, including Jardiance (empagliflozin)...
by Kim Yun-mi
|
2020-06-15 17:39
라인
‘Loose restrictions may push daily infections to 800 one month later’
The continued cluster infections in the Seoul metro region without stronger...
by Song Soo-youn
|
2020-06-15 15:46
라인
SK Biopharmaceuticals to expand global presence with IPO
SK Biopharmaceuticals expressed its aspiration to become a global leader in...
by Lee Han-soo
|
2020-06-15 12:51
라인
Fears of mass infections linger amid unabated spreads in greater Seoul
New virus cases stayed below 40 for the second day but cluster infections a...
by Shim Hyun-tai
|
2020-06-15 12:51
라인
Biogen’s FDA application for Alzheimer’s drug drags on
Biogen’s filing of aducanumab, an investigational Alzheimer’s drug, for U.S...
by Kim Yun-mi
|
2020-06-15 12:09
라인
Survey paints gloomy outlook for Korea’s developing Covid-19 treatment
About 60 percent of workers in the domestic pharmaceutical industry predict...
by Shim Hyun-tai
|
2020-06-12 17:56
라인
PharmAbcine inks CDMO deal with Australian firm for immunotherapy candidate
PharmAbcine, an antibody new drug developer, has signed a CDMO (contract de...
by Lee Han-soo
|
2020-06-12 17:15
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top